Machine Learning Integration of Serial Blood Biomarkers Enhances Cognitive Decline Prediction in Early Parkinson's Disease

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Abstract Cognitive decline is a major non-motor complication in early Parkinson’s disease (PD), but predicting its progression remains challenging. Using data from 193 participants in the Early Parkinson’s Disease Longitudinal Singapore (PALS) cohort, we evaluated whether longitudinal blood biomarkers—neurofilament light chain (NfL) and total tau (t-tau)—could improve prediction of cognitive decline, defined as a one-point annual or sustained two-year drop in Montreal Cognitive Assessment scores. We applied three variable selection methods and five machine learning models across seven feature sets. Overall, 23% of participants experienced cognitive decline over five years. The XGBoost model trained on Random Forest–selected variables achieved the highest performance (AUC = 0.806), a substantial improvement over the baseline-only model (AUC = 0.560). Key predictors included diastolic blood pressure and summaries of t-tau and NfL. Time-varying biomarkers improved predictions over baseline data alone, supporting their integration with machine learning for early cognitive risk assessment in PD.

Related topics